Scarica l'app Stockscreener
1.54
1.91%
-0.03
Dopo l'orario di chiusura:
1.56
0.02
+1.30%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Precedente Chiudi:
$1.57
Aprire:
$1.565
Volume 24 ore:
4.44M
Relative Volume:
1.11
Capitalizzazione di mercato:
$1.04B
Reddito:
$863.49M
Utile/perdita netta:
$-188.86M
Rapporto P/E:
-5.7037
EPS:
-0.27
Flusso di cassa netto:
$-44.47M
1 W Prestazione:
-3.14%
1M Prestazione:
-2.53%
6M Prestazione:
+24.19%
1 anno Prestazione:
-1.28%
Intervallo 1D:
$1.53
$1.57
Intervallo di 1 settimana:
$1.53
$1.65
Portata 52W:
$0.8516
$1.76
Opko Health Inc Stock (OPK) Company Profile
Nome
Opko Health Inc
Settore
Industria
Telefono
305-575-4181
Indirizzo
4400 BISCAYNE BLVD., MIAMI, FL
Confronta OPK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.54 | 1.04B | 863.49M | -188.86M | -44.47M | -0.25 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-06-29 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | Iniziato | Ladenburg Thalmann | Buy |
| 2019-11-25 | Iniziato | Piper Jaffray | Overweight |
| 2018-03-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-09-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2016-06-21 | Reiterato | Standpoint Research | Buy |
| 2016-06-03 | Iniziato | Standpoint Research | Buy |
| 2016-03-31 | Reiterato | Barrington Research | Outperform |
| 2015-10-16 | Iniziato | JP Morgan | Overweight |
| 2015-09-11 | Downgrade | Jefferies | Buy → Hold |
| 2015-03-03 | Downgrade | Oppenheimer | Outperform → Perform |
| 2014-05-12 | Reiterato | Oppenheimer | Outperform |
| 2014-03-14 | Iniziato | Oppenheimer | Outperform |
| 2013-11-13 | Reiterato | Ladenburg Thalmann | Buy |
| 2013-05-30 | Reiterato | Ladenburg Thalmann | Buy |
| 2012-10-22 | Iniziato | Barrington Research | Outperform |
| 2011-12-01 | Reiterato | Ladenburg Thalmann | Buy |
| 2011-07-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Opko Health Inc Borsa (OPK) Ultime notizie
Esoteric Testing Market is Set to Experience a Revolutionary Growth | Labcorp, Quest Diagnostics, OPKO Health - openPR
Connected Drug Delivery Devices Market is Dazzling Worldwide - openPR
OPKO Health (NASDAQ:OPK) Raised to Hold at StockNews.com - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) CEO Buys $198,750.00 in Stock - MarketBeat
Phillip Frost Buys Handful Of Shares In OPKO Health - Simply Wall St
Opko health CEO Phillip Frost buys $199,375 in stock By Investing.com - Investing.com South Africa
Opko health CEO Phillip Frost buys $199,375 in stock - Investing.com
Opko Health stock hits 52-week high of $1.75 amid growth - Investing.com Canada
Opko Health stock hits 52-week high of $1.75 amid growth By Investing.com - Investing.com South Africa
Opko health CEO Phillip Frost purchases $781,050 in shares By Investing.com - Investing.com Canada
Charles Schwab Investment Management Inc. Decreases Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Opko health CEO Phillip Frost purchases $781,050 in shares - Investing.com
Is OPKO Health (OPK) the Best NASDAQ Penny Stock to Buy Right Now? - Insider Monkey
11 Best NASDAQ Penny Stocks To Buy Right Now - Insider Monkey
NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer - Marketscreener.com
NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer – Company AnnouncementFT.com - Financial Times
Global Clinical Laboratory Tests Market Forecast for 2024 - openPR
OPKO Health (NASDAQ:OPK) investors are sitting on a loss of 59% if they invested three years ago - Yahoo Finance
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - The Eastern Progress Online
Buy, Sell, or Hold: Opko Health - AOL
Further weakness as OPKO Health (NASDAQ:OPK) drops 4.9% this week, taking three-year losses to 60% - Simply Wall St
OPKO Health, Inc. (NASDAQ:OPK) CEO Purchases $304,580.16 in Stock - MarketBeat
Opko health CEO Phillip Frost buys $305,376 in shares By Investing.com - Investing.com Australia
Opko health CEO Phillip Frost buys $305,376 in shares - Investing.com
Tranche Update on OPKO Health, Inc.'s Equity Buyback Plan announced on July 18, 2024. - Marketscreener.com
Rubric Capital Management LP Increases Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Opko health CEO Phillip Frost buys $159k in common stock - Investing.com India
Opko health CEO Phillip Frost buys $159k in common stock By Investing.com - Investing.com South Africa
Phillip Md Et Al Frost Acquires 100,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
OPKO Health To Participate In The Piper Sandler 36th Annual Healthcare Conference - Barchart
OPKO Health (OPK) Q3 Earnings Surpass Estimates - MSN
NextPlat (NASDAQ: NXPL) Expands OPKO Product Promotion at Asia’s Largest Health Expo - The Globe and Mail
Hyperparathyroidism Treatment Market Growth Trends, Regional - openPR
NextPlat to Showcase OPKO Healthcare Products at Major Chinese Health Expo | NXPL Stock News - StockTitan
OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts - MSN
NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo - PR Newswire
OPKO Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Opko health CEO Phillip Frost buys $161,980 in stock - Investing.com
NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results - WV News
Rubric Capital Management LP's Strategic Acquisition in OPKO Hea - GuruFocus.com
Barrington Research Estimates OPKO Health FY2028 Earnings - MarketBeat
Insider Buying: OPKO Health Chairman & CEO Bought US$422k Of Shares - Simply Wall St
OPKO Health: Q3 Earnings Snapshot - AOL
Opko Health Inc Azioni (OPK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Opko Health Inc Azioni (OPK) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 11 '24 |
Buy |
1.56 |
500,000 |
781,050 |
212,411,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 29 '24 |
Buy |
1.53 |
199,072 |
305,376 |
211,911,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 22 '24 |
Buy |
1.59 |
100,000 |
159,000 |
211,712,405 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 14 '24 |
Buy |
1.62 |
100,000 |
161,980 |
211,612,405 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 08 '24 |
Buy |
1.50 |
280,183 |
421,535 |
211,512,405 |
0.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):